https://www.selleckchem.com/products/AG-490.html
Special emphasis is given to the spectrum of spontaneous background myocardial pathology that might be encountered during preclinical studies conducted to identify potential cardiotoxic actions of anticancer agents. © This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply. 2019.Background The management of patients with cancer and concurrent heart failure (HF) is challenging. The increased complexity of treatment and the occurrence of multiple overlapping symptoms may lead to f
Like
Comment
Share
